ArticleJAAD international2024
Burden of chronic skin disease from an Asian perspective: Assessment of health state utilities and quality of life in a Singapore cohort.
Article in JAAD international, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Health-related quality of life in patients with psoriasis in Asian countries: a systematic review and meta-analysis of EQ-5D utility scores.Scientific reports · 2026Pooled it
- Economic Evaluation of a Digital Psychobehavioral Intervention for Chronic Inflammatory Skin Disease (MindMySkin): Protocol for a Trial-Based Cost-Effectiveness Analysis.JMIR research protocols · 2026Article
- Article
- Neomycin sulfate and triamcinolone acetonide suspended ointment designed for transdermal delivery: formulation and in vitro evaluation.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Understanding health state utilities of skin diseases is essential for health economic evaluations in an era of rising health care costs. Objective: To create a catalog of utility values of chronic skin diseases among Asians. Methods: This is a cross-sectional study of adults attending a dermatology outpatient clinic from February 2019 to March 2023 with one of the following skin diseases: (1) eczema, (2) psoriasis, (3) acne vulgaris, (4) chronic urticaria, (5) pigmentary disorders, (6) hair loss, (7) viral warts, (8) fungal infections, and (9) keloids. Demographic and socioeconomic information was collected. Health status and utilities (Dermatology Life Quality Index, Skindex-16, EuroQol-5 Dimension, visual analog scale, time-trade-off, and willingness-to-pay) were measured. Results: A total of 183 patients with a median age of 35.5 (21-77 years) years were included. Majority (76.9%) were Chinese, followed by Malays (11.5%). The time-trade-off utilities were lower than EuroQol-5 Dimension utilities across all disease severity and most skin diseases. Patients were willing to pay $740 USD or more for a hypothetical drug to cure conditions such as psoriasis, acne, hair loss, and keloids. Limitations: Limited sample size and ethnic representation. Conclusions: This study provides a catalog of utilities in skin diseases and highlights the strengths and challenges of different measures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.